XML 70 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Total revenue $ 320.2 $ 293.8 $ 298.3
Cost of sales 208.1 175.9 183.8
Gross profit (loss) 112.1 117.9 114.5
Advanced technology license and decommissioning costs 14.2 14.8 2.1
Selling, general and administrative 35.6 33.9 36.0
Amortization of intangible assets 6.3 9.0 8.1
Special charges for workforce reductions and advisory costs 3.6 0.5 0.0
Operating income (loss) 52.4 59.7 68.3
Nonoperating components of net periodic benefit expense (income) (23.2) (6.6) (67.6)
Interest expense 1.3 0.5 0.1
Investment income (8.7) (2.0) (0.1)
Other Nonoperating Income (1.5) 0.0 0.0
Income (loss) before income taxes 84.5 67.8 135.9
Provision (benefit) for income taxes 0.1 15.6 (39.1)
Net income (loss) 84.4 52.2 175.0
Distributed earnings allocable to warrant modification 0.0 1.5 0.0
Preferred stock dividends, undeclared and cumulative 0.0 0.0 2.1
Distributed earnings allocable to retired preferred shares 0.0   37.6
Net income (loss) allocable to common stockholders $ 84.4 $ 50.7 $ 135.3
Net income (loss) per common share - basic $ 5.55 $ 3.47 $ 10.03
Net income (loss) per common share - diluted $ 5.44 $ 3.38 $ 9.75
Weighted-average number of shares outstanding:      
Average number of shares outstanding, basic 15,212 14,601 13,493
Average number of shares outstanding, diluted 15,501 14,988 13,879
Accumulated Deficit [Member]      
Net income (loss) $ 84.4 $ 52.2 $ 175.0
Distributed earnings allocable to warrant modification 0.0 1.5 0.0
Product [Member]      
Total revenue 269.0 235.6 186.1
Cost of sales 163.9 105.0 113.1
Separative Work Units [Member]      
Total revenue 208.2 196.2 163.3
Uranium [Member]      
Total revenue 60.8 39.4 22.8
Service [Member]      
Cost of sales $ 44.2 $ 70.9 $ 70.7